Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised study

Sue Ann Costa Clemens; Lily Weckx; Ralf Clemens; Ana Verena Almeida Mendes; Alessandra Ramos Souza; Mariana B V Silveira; Suzete Nascimento Farias da Guarda; Maristela Miyamoto de Nobrega; Maria Isabel de Moraes Pinto; Isabela G S Gonzalez; Natalia Salvador; Marilia Miranda Franco; Renata Navis de Avila Mendonça; Isabelle Silva Queiroz Oliveira; Bruno Solano de Freitas Souza; Mayara Fraga; Parvinder Aley; Sagida Bibi; Liberty Cantrell; Wanwisa Dejnirattisai; Xinxue Liu; Juthathip Mongkolsapaya; Piyada Supasa; Gavin R Screaton; Teresa Lambe; Merryn Voysey; Andrew J Pollard; Mustapha Bittaye; Danielle Woods; Sophie Davies; Holly Smith; Marta Ulaszewska; Helen Sanders; Reece Mabette; Sophie Vernon; Zara Valliji; Gracie Mead; Chitra Tejpal; Juyeon Park; Amy Beveridge; Ahmed Eldawi; Sally Felle; Mayara Fraga; Thaiane Muniz Martins; Claudia Loureiro Martins Medrado; Laiana Januse de Arruda Cordeiro Matos

The Lancet (2022) - Comments
pubmed: 35074136 doi: 10.1016/s0140-6736(22)00094-0 issn: 0140-6736 issn: 1474-547x

Sue Ann Costa Clemens, Lily Weckx, Ralf Clemens, Ana Verena Almeida Mendes, Alessandra Ramos Souza, Mariana B V Silveira, Suzete Nascimento Farias Da Guarda, Maristela Miyamoto De Nobrega, Maria Isabel De Moraes Pinto, Isabela G S Gonzalez, Natalia Salvador, Marilia Miranda Franco, Renata Navis De Avila Mendonça, Isabelle Silva Queiroz Oliveira, Bruno Solano De Freitas Souza, Mayara Fraga, Parvinder Aley, Sagida Bibi, Liberty Cantrell, Wanwisa Dejnirattisai